Sorafenib also contributes to apoptosis in HCC when used in combination with IFN-α, due to its suppressive effects and cell cycle arresting, and induction of apoptosis through activation of proteins related to cell cycle arrest such as Bcl-XL, Mcl-1, and Bcl-2 [103]. Here, BCL2L1 is linked to hepatocellular carcinoma.